
Please try another search
Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company’s product portfolio includes Shuanghuanglian oral solutions and Shuanghuanglian injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products. It also offers small and large volume injections, oral liquids, tablets, capsules, granules, traditional Chinese medicine extracts, and chemical synthesis. In addition, the company provides business management and consulting services; and engages in the sale of construction material and electricity. It offers its medicines for the treatment of heat-clearing and detoxification, cardiovascular and cerebrovascular, antihypertensive and hypoglycemic, tonifying, qi-regulating, anti-anemia, and antibacterial and anti-inflammatory. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Name | Age | Since | Title |
---|---|---|---|
Kwok Tung Lee | 56 | 2019 | Independent Non-Executive Director |
Kit Wa To | 50 | 2020 | Independent Non-Executive Director |
Wing Chun Sze | 47 | 2018 | Independent Non-Executive Director |
Qingfen Meng | 60 | 2017 | Executive Director |
Zhiming Cao | 39 | 2013 | CEO & Executive Chairman |
Taisheng Hou | 62 | 2017 | Executive Director |
Yongsheng Chi | 63 | 2017 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review